News
Announcement: Mireille Sanders new member of Supervisory Board at BioConnection
Oss, NL May 20, 2025 BioConnection is pleased to announce the appointment of Mireille Sanders as member of our Supervisory Board. She succeeds Sijmen de Vries at this position who steps back at the same time. We are happy that Ms. Sanders continues this position on...
Announcement: Mireille Sanders new member of Supervisory Board at BioConnection
Oss, NL May 20, 2025 BioConnection is pleased to announce the appointment of Mireille Sanders as member of our Supervisory Board. She succeeds Sijmen de Vries at this position who steps back at the same time. We are happy that Ms. Sanders continues this position on...
Strategic partnership AGC Biologics and BioConnection
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and BioConnection, a specialized...
BioConnection congratulates BioLineRx with their FDA approval of Aphexda
BioConnection congratulates BioLineRx with their FDA approval of Aphexda. We are proud that we have been able to support BioLineRx since the start...
Dutch CDMO BioConnection announces substantial investment by Gimv, supported by existing shareholders
New capital secures growth acceleration in services for small to medium sized biopharmaceutical companies and further enhancement of quality control...
BioConnection to manufacture clinical trial material for Nykode Therapeutics’ vaccine
Oss, The Netherlands, 29 November 2021 BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The...
GMP certification for new large scale filling line
Oss, The Netherlands, June 28, 2021. BioConnection received today from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and...
BioConnection is honoured to support VarmX
With the EU and US GMP capabilities from our facility in Oss, BioConnection is proud to assist VarmX to accelerate the GMP manufacturing trajectory...